MedTech Industry Dynamics
MedTech Industry Dynamics
HistoSonics has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison Histotripsy System, marking another milestone in its international expansion and creating opportunities to advance access to histotripsy across the Asia-Pacific region.
Read MoreSingapore’s Health Sciences Authority has announced three initiatives to speed healthcare innovations to patients, including an AI-focused Regulatory Innovation Corridor with the UK’s MHRA, a common entry point for clinical research and regulatory engagement, and a priority track allowing concurrent regulatory and health technology assessment.
Read MoreNational University Hospital is expanding wearable technology for patient monitoring following a successful pilot that found continuous smartwatch monitoring could detect vital sign changes up to two hours earlier than routine manual observations.
Read MoreALR Technologies has entered into a Letter of Intent to acquire CGM Medical Technology Singapore and assets of CGM Medical Shenzhen for an aggregate purchase price of US$45 million and 200 million ordinary shares, with the goal of becoming a fully integrated diabetes management company.
Read MoreBiobot Surgical has raised S$20 million in a financing round led by ClavystBio with support from ZIG Ventures, with proceeds supporting global commercialization of its Mona Lisa robotic-assisted prostate care platform and establishing a U.S. market presence.
Read MoreSingapore’s National University Hospital and NUS Medicine have launched a new Molecular Imaging and Theranostics Centre equipped with the country’s first total-body PET/CT system, advancing cancer diagnostics, research and personalised treatment.
Read MoreShape Memory Medical has received regulatory approvals from Singapore and Malaysia to market its IMPEDE Embolization Plug family, expanding its presence in Asia through its regional partner Getz Healthcare.
Read MoreThe National Cancer Centre Singapore (NCCS) marked its 25th anniversary with a charity dinner that raised S$20.5 million to strengthen cancer research, AI drug discovery, and patient support initiatives.
Read MoreNew partnership integrates RADPAIR’s AI-driven reporting into AdvaPACS, offering radiologists enhanced efficiency within cloud-native workflows.
Read MoreBody Vision Medical secures HSA approval for LungVision®, bringing AI-driven 3D imaging to bronchoscopic lung cancer diagnostics in Singapore.
Read More
